Recall of DIMENSION XPAND SYSTEM - ENZYMATIC CREATININE (EZCR) ASSAY

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by SIEMENS HEALTHCARE LIMITED.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    56588
  • Event Risk Class
    II
  • Event Initiated Date
    2010-06-24
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Siemens healthcare diagnostics received customer complaints regarding the dimension enzymatic creatinine (ezcr) flex reagent cartridge. siemens recently confirmed an issue which may cause ezcr elevations across the assay range. this issue may or may not be detected by quality control as the degree and onset of elevated results may vary and is likely dependent on multiple factors such as method mix or instrument maintenance.

Device

  • Model / Serial
    Model Catalog: DF270B (Lot serial: BD1008); Model Catalog: DF270B (Lot serial: CB1050)
  • Product Description
    ENZYMATIC CREATININE (EZCR) FLEX REAGENT CARTRIDGES DF270B
  • Manufacturer

Manufacturer

  • Manufacturer Address
    OAKVILLE
  • Manufacturer Parent Company (2017)
  • Source
    HC